We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

61 hedge funds and large institutions have $38.9M invested in Orchard Therapeutics plc American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 16

15% less funds holding

Funds holding: 72 → 61 (-11)

54% less capital invested

Capital invested by funds: $84.6M → $38.9M (-$45.7M)

56% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 18

Holders
61
Holders Change
-11
Holders Change %
-15.28%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
14
Reduced
16
Closed
18
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
+$104K

Top Buyers

Rank Fund Capital Flow
1
SG Americas Securities
SG Americas Securities
New York
+$395K
2
BlackRock
BlackRock
New York
+$122K
3
Bank of America
Bank of America
North Carolina
+$53.2K
4
FA
Forefront Analytics
Pennsylvania
+$46.2K
5
GCP
GSA Capital Partners
United Kingdom
+$34.8K

Top Sellers

Rank Fund Capital Flow
1
Artisan Partners
Artisan Partners
Wisconsin
-$4.39M
2
PIM
Platinum Investment Management
Australia
-$1.76M
3
CA
CHI Advisors
New York
-$1.12M
4
Two Sigma Investments
Two Sigma Investments
New York
-$716K
5
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$620K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
51
Aquatic Capital Management
Illinois
$3K +$3.33K +340 +850%
QT
52
Quantbot Technologies
New York
$2K – – –
Barclays
53
Barclays
United Kingdom
$1K – – –
Osaic Holdings
54
Osaic Holdings
Arizona
$1K – – –
SPIA
55
Steward Partners Investment Advisory
New York
$1K – – –
CWP
56
Concord Wealth Partners
Virginia
$1K +$588 +60 +150%
CAPTRUST Financial Advisors
57
CAPTRUST Financial Advisors
North Carolina
$1K +$735 +75 New
PIM
58
Platinum Investment Management
Australia
– -$1.76M -133,517 Closed
Two Sigma Investments
59
Two Sigma Investments
New York
– -$716K -54,221 Closed
WP
60
Woodline Partners
California
– -$477K -36,174 Closed
AFM
61
Anson Funds Management
Texas
– -$460K -34,827 Closed
Millennium Management
62
Millennium Management
New York
– -$189K -14,299 Closed
Acadian Asset Management
63
Acadian Asset Management
Massachusetts
– -$141K -10,817 Closed
Jane Street
64
Jane Street
New York
– -$106K -8,065 Closed
Susquehanna International Group
65
Susquehanna International Group
Pennsylvania
– -$89K -6,747 Closed
Group One Trading
66
Group One Trading
Illinois
– -$51.2K -5,226 Closed
TSS
67
Two Sigma Securities
New York
– -$61K -4,631 Closed
EGM
68
Engineers Gate Manager
New York
– -$40K -3,033 Closed
Marshall Wace
69
Marshall Wace
United Kingdom
– -$31K -2,355 Closed
E
70
Ergoteles
New York
– -$31K -2,317 Closed
Simplex Trading
71
Simplex Trading
Illinois
– -$17.4K -1,777 Closed
Squarepoint
72
Squarepoint
New York
– -$19K -1,474 Closed
KPWS
73
Kestra Private Wealth Services
Texas
– -$13K -1,003 Closed
MC
74
Matisse Capital
Oregon
– -$13K -1,000 Closed
EWM
75
Edge Wealth Management
New York
– -$1K -22 Closed
1 2
3
4

ORTX Hedge Fund Activity: Q1 2022 in Review

61 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q1 2022, worth a combined $38.9M — down 54% from $84.6M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of ORTX and 8 opened new positions — a net loss of 10 holders — while 16 trimmed existing stakes and 14 added.

The largest buyer was SG Americas Securities, adding an estimated $395K. The largest seller was Artisan Partners, cutting an estimated $4.39M.

  • 61 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q1 2022, down from 72 in Q4 2021.
  • Funds reported $38.9M of Orchard Therapeutics plc American Depositary Shares stock for Q1 2022, down 54% quarter-over-quarter.
  • 8 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q1 2022 and 18 closed out, a net change of -10 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q1 2022 was SG Americas Securities, an estimated $395K added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q1 2022 was Artisan Partners, an estimated $4.39M sold.

Based on aggregated 13F filings for Q1 2022.